EUVIMEDEUVIMED entdecken
Multizentrische Studie

Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis

Chiara De Mutiis iD, Scott E Wenderfer, Biswanath Basu, Arvind Bagga, Alvaro Orjuela, Tanmoy Sar, Amita Aggarwal, Avinash Jain, Olivia Boyer, Hui-Kim Yap, Shuichi Ito, Ai Ohnishi und 11 weitere

Pediatric Nephrology · 2024

DOI: 10.1007/s00467-024-06405-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Nephrology, 2024. Verfasst von Chiara De Mutiis und 22 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Unit, Maggiore Hospital, Azienda USL, Bologna, Italy. chiarademutiis@yahoo.com. Hauptthemen laut MEDLINE: Lupus Nephritis, Biomarkers, Glomerular Filtration Rate. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lupus nephritis (LN) is a very severe manifestation of lupus. There is no consensus on which treatment goals should be achieved to protect kidney function in children with LN. METHODS: We retrospectively analyzed trends of commonly used laboratory biomarkers of 428 patients (≤ 18 years old) with biopsy-proven LN class ≥ III. We compared data of patients who developed stable kidney remission from 6 to 24 months with those who did not. RESULTS: Twenty-five percent of patients maintained kidney stable remission while 75% did not. More patients with stable kidney remission showed normal hemoglobin and erythrocyte sedimentation rate from 6 to 24 months compared to the group without stable kidney remission. eGFR ≥ 90 ml/min/1.73m2 at onset predicted the development of stable kidney remission (93.8%) compared to 64.7% in those without stable remission (P < 0.00001). At diagnosis, 5.9% and 20.2% of the patients showed no proteinuria in the group with and without stable kidney remission, respectively (P = 0.0001). dsDNA antibodies decreased from onset of treatment mainly during the first 3 months in all groups, but more than 50% of all patients in both groups never normalized after 6 months. Complement C3 and C4 increased mainly in the first 3 months in all patients without any significant difference. CONCLUSIONS: Normal eGFR and the absence of proteinuria at onset were predictors of stable kidney remission. Significantly more children showed normal levels of Hb and erythrocyte sedimentation rate (ESR) from 6 to 24 months in the group with stable kidney remission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisBiomarkersGlomerular Filtration RateHumansChildFemaleMaleRetrospective StudiesAdolescentBlood SedimentationRemission InductionKidneyComplement C3Antibodies, AntinuclearProteinuriaComplement C4Child, Preschool

Stichwörter der Autor:innen

BiomarkersLupus nephritisPediatricProteinuriaRemissioneGFR

Substanzen

BiomarkersComplement C3Antibodies, AntinuclearComplement C4

Autor:innen und Institutionen

  • Paediatric Unit, Maggiore Hospital, Azienda USL, Bologna, Italy. chiarademutiis@yahoo.com.
  • Pediatric Nephrology, The University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada.
  • Division of Pediatric Nephrology, Department of Pediatrics, Nilratan Sircar Medical College and Hospital, Kolkata, India.
  • Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
  • Pediatric Nephrology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

ORCID-Profile: Chiara De Mutiis

Zitieren

APA

De Mutiis, C., Wenderfer, S. E., Basu, B., Bagga, A., Orjuela, A., Sar, T., Aggarwal, A., Jain, A., Boyer, O., Yap, H. K., Ito, S., Ohnishi, A., Iwata, N., Kasapcopur, O., Laurent, A., Chan, E. Y., Mastrangelo, A., Ogura, M., Shima, Y., …, & Tullus, K. (2024). Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06405-6

Vancouver

De Mutiis C, Wenderfer SE, Basu B, Bagga A, Orjuela A, Sar T, et al. Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis. Pediatric Nephrology. 2024. doi:10.1007/s00467-024-06405-6

BibTeX
@article{DeMutiis2024,
  author = {De Mutiis, Chiara and Wenderfer, Scott E and Basu, Biswanath and Bagga, Arvind and Orjuela, Alvaro and Sar, Tanmoy and Aggarwal, Amita and Jain, Avinash and Boyer, Olivia and Yap, Hui-Kim and Ito, Shuichi and Ohnishi, Ai and Iwata, Naomi and Kasapcopur, Ozgur and Laurent, Audrey and Chan, Eugene Yu-Hin and Mastrangelo, Antonio and Ogura, Masao and Shima, Yuko and Rianthavorn, Pornpimol and Silva, Clovis A and Trindade, Vitor and Tullus, Kjell},
  title = {Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis},
  journal = {Pediatric Nephrology},
  year = {2024},
  doi = {10.1007/s00467-024-06405-6}
}
Kostenlos starten →